Impact Factor
2.85
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.61
207 total citations
h5-index
19
h5 depth signal
Cited share
64.8%
94 of 145
Total citations
207
Citation footprint
Metric signal
1.48
External metric anchor
Self-citation
0.5%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
388
China
147
Egypt
65
India
64
Italy
63
Citing Fields of Research
Oncology
334
Breast Cancer
195
Cancer & Development
148
Musculoskeletal & Nerve Cancer
128
Immunology
121
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,801
Articles tracked across the journal lifetime
Indexed publication set
145
94 cited publications
Last 12 months
75
6.3 publications/month
Open access share
12.0%
9 OA publications in the last year
Leading citing country
United States
388 citing publications
Leading citing field
Oncology
334 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v8n1, Mar. 2000-
v8n1, Mar. 2000-
Active Coverage
Research Focus & Classification
Indexed Subjects
Breast Cancer
Oncology
Musculoskeletal & Nerve Cancer
Lymphomas
Immunology
Cancer & Development
Issuing & Sponsoring Bodies
Contributor
Society for Applied Immunohistochemistry
Broad Categories
Histocytochemistry
Molecular Biology
Immunology
Urology
Breast Cancer
Liver & Colon Cancer
Musculoskeletal & Nerve Cancer
Dermatology
Brain Imaging
MeSH Descriptors
Cells
Cytological Techniques
Immunohistochemistry
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/pai.0000000000001361
Open DOI
Complementary Diagnostic Value of ZEB1 and CK7 in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Renal oncocytoma (RO) is a benign renal epithelial tumor that may closely mimic chromophobe renal cell carcinoma (chRCC), particularly in limited biopsy specimens. In addition, the expanding spectrum of oncocytic renal neoplasms further ...
02
DOI 10.1097/pai.0000000000001348
Open DOI
Punctate Nuclear MLH1 Staining With the VENTANA M1 Clone in Colorectal Carcinoma: Identification of 3 Patterns in Matched Biopsy-Resection Specimens
In colorectal carcinoma (CRC), deficient DNA mismatch repair (dMMR) is an established predictive and prognostic biomarker and an essential screening marker for Lynch syndrome. Immunohistochemistry (IHC) for MLH1, PMS2, MSH2, and MSH6 is ...
03
DOI 10.1097/pai.0000000000001364
Open DOI
Interobserver Reproducibility of Treatment-Defining HER2-Low and HER2-Ultralow Immunohistochemical Scoring in Breast Carcinoma: A Systematic Review
Eligibility for trastuzumab deruxtecan now depends on separating HER2 immunohistochemistry (IHC) score 0 from 1+ (HER2-low) and, within score 0, null from ultralow staining—boundaries the assay was not designed to resolve. We systematica...
04
DOI 10.1097/pai.0000000000001363
Open DOI
Diagnostic Utility of SS18-SSX Fusion-Specific and SSX C-Terminus Antibodies in Synovial Sarcoma: Validation in a Large Indian Tertiary Care Cohort
Diagnosis of synovial sarcoma (SS) requires molecular confirmation of the SS18-SSX fusion by FISH or RT-PCR, but these methods are costly and limited in resource-constrained settings. Recently developed fusion-specific antibodies offer p...
05
DOI 10.1097/pai.0000000000001362
Open DOI
Comparative Evaluation of Immunohistochemistry With DNA Methylation Profiling for Molecular Classification of Medulloblastomas: A Single-Institution Cohort Study
Medulloblastoma is an embryonal tumor of the central nervous system that is divided into 3 molecular subgroups: WNT-activated, SHH-activated, and non-WNT/non-SHH-activated. The latter comprises group 3 and group 4. Given significant prog...
06
DOI 10.1097/pai.0000000000001356
Open DOI
Optimizing Immunohistochemical Detection of Matriglycan in Muscles of Dystroglycanopathy
Detection of matriglycan on α-dystroglycan by immunohistochemistry is one of the essential approaches for studying the mechanisms of functional glycosylation of α-DG, the pathogenesis of dystroglycanopathy, and developing experimental th...
07
DOI 10.1097/pai.0000000000001360
Open DOI
PRAME as a Diagnostic Adjunct in Clear Cell Sarcoma
Clear cell sarcoma (CCS) is a rare soft tissue neoplasm characterized by melanocytic differentiation and recurrent EWSR1 rearrangements. Owing to its overlapping morphology and immunophenotype with malignant melanoma (MM), distinction be...
08
DOI 10.1097/pai.0000000000001358
Open DOI
Autophagy- and Stress-Related Biomarkers in Pretreatment Rectal Adenocarcinoma Biopsies: Associations With Pathologic Response to Neoadjuvant Therapy and Survival
Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal adenocarcinoma, yet therapeutic response varies widely and reliable biomarkers are lacking. This study evaluated the immunohistochemical expressio...
09
DOI 10.1097/pai.0000000000001351
Open DOI
Inflammatory Rhabdomyoblastic Tumor: A Clinicopathological and Immunohistochemical Study of 22 Cases
Inflammatory rhabdomyoblastic tumor (IRMT) is a newly defined subtype of skeletal muscle neoplasm with uncertain malignant potential. Herein, we present a series of 22 IRMT cases to further expand its clinical and pathologic spectrum. Th...
10
DOI 10.1097/pai.0000000000001355
Open DOI
The Application of RNAscope Protocol to Detect Dengue Virus in Human Paraffin-Embedded Tissue
Dengue is an important arthropod-borne viral disease, endemic in over 100 countries and challenging health care systems worldwide São Paulo, Brasil. The disease can be clinically diagnosed by the detection of dengue-specific antibodies, ...
Bibliographical & Catalog Notes
Title from cover.
Issues for Mar. 1999- carry also season designation, spring 1999-
Also issued online.
Formed by the union of: Applied immunohistochemistry, and: Cell vision, and continues the numbering of the former.